Content |
Main departments
- Oral cavity
- Throat
- Gullet
- Stomach
- Small intestine
- Colon
- Rectum
Chronicle
2024
Construction in the Moscow region of an enterprise for the production of drugs for gastrointestinal research
In the city district of Fryazino, Moscow Region, the Vips-Med company completed the construction of a production and warehouse complex for the production of a radiopaque contrast agent used in gastrointestinal tract studies. The object was erected on a site received as part of the regional import substitution program "Earth for 1 ruble." This became known on October 24, 2024. Read more here
For the first time, a person successfully transplanted the larynx and throat
On February 29, 2024, a patient in the United States successfully transplanted the larynx and pharynx. This became known in July 2024.
Marty Kedian has undergone pioneering surgery that offers hope to thousands of people who have lost their voices and the ability to swallow and breathe on their own due to impaired laryngeal function or total laryngeal loss, Mayo Clinic reports.
Marty underwent his first surgery in 2014. Dozens more followed over the next 10 years, dropping Marty's voice to a raucous whisper. No longer able to breathe on his own, Marty underwent surgery to insert a tracheostomy tube so he could breathe through a hole in the front of his neck.
Wherever I went, the first thing I was asked was, "How many cigarettes did you smoke a day?" I haven't smoked a single cigarette in my life, "Marty says. People immediately closed and retreated from me. After a while, I just didn't want to go anywhere. I was alive, but I didn't live. |
This is the third known laryngeal transplant in the United States and the first known case performed on a patient with active cancer as part of a clinical trial. It is also the first total laryngeal transplant at the Mayo Clinic. Experts say Mayo laryngeal transplantation is a key milestone in making this rare procedure available as a scientifically proven, safe and effective procedure for the wider population.
Removing cancer was a top priority of the surgical team. As Dr Lott, who led the operation, explained, surgeons first removed the cancer-affected larynx. It wasn't until the team made sure the cancer was gone that surgeons moved on to transplants.
In addition to the larynx, surgeons transplanted the pharynx, upper trachea, upper esophagus, thyroid and parathyroid glands, blood vessels and nerves.
Four months after the transplant, Marty regained 60% of his vote. Doctors say his condition will continue to improve as he recovers over the next year. He also regained the ability to swallow and breathe on his own. Doctors plan to remove the tracheostomy tube when Marty fully regains the ability to breathe on her own.[1]
2023
Surgical sealant developed for "leaky intestines"
On June 15, 2023, Swiss researchers from the Federal Laboratories of Materials Science and Technology (EMPA) announced the development of a new type of surgical sealant that could warn doctors of intestinal insolvency after gastrointestinal (GI) surgery. Read more here.
A swallowed capsule with a remote-controlled video camera is presented to diagnose digestive problems
On June 1, 2023, American researchers from the School of Medicine and Health at George Washington University announced the development of an innovative guided video capsule designed to diagnose digestive problems. Read more here.
A smart capsule has been created that accelerates appetite
On April 26, 2023, US researchers at the Massachusetts Institute of Technology (MIT) reported the development of a swallowed capsule that stimulates appetite and prevents the body from wasting as a result of malnutrition. Read more here.
Diagnostic capsule with GPS analogue for intestines created
In mid-February 2023, American scientists announced the development of a platform that allows 3D to track the location of a small diagnostic capsule when it passes through the gastrointestinal tract (GI). Read more here.
2022: Universal way to manage pain in various GI diseases revealed
On December 23, 2022, researchers from Flinders University in Australia reported a new discovery that could lead to the emergence of advanced ways to combat chronic pain associated with various gastrointestinal disorders (GI), such as irritable bowel syndrome.
Specialists from the University of Washington in the United States took part in the work. Scientists say that the development of selective painkillers for the gastrointestinal tract is difficult due to the lack of a clear understanding of how sensory neurons transmit signals from the intestine to the brain. It was previously known that various ion channels are involved in this mechanism. Now the main one has been identified: it is located in the colon and responds to mechanical irritation, leading to a feeling of pain.
As the researchers managed to establish, a Piezo2, a receptor, is involved in the work of this channel, for the discovery of which the Nobel Prize in Physiology was awarded in 2021. Piezo2, among other things, is responsible for touch and proprioception, that is, the feeling of the position of parts of one's own body relative to each other and in space. In the case of GI, as it turned out, the main ion channel responsible for mechanical pain also uses Piezo2. Thus, it becomes possible to develop targeted painkillers for the intestine.
Based on this knowledge, we can focus on targeting these channels to drown out pain and hopefully develop a treatment for visceral pain common in conditions such as irritable bowel syndrome, endometriosis, or abdominal cancer, while avoiding the devastating side effects of other drugs used, said Professor Nick Spencer of Flinders University.[2] |